Davidson Kempner Capital Management LP Graphite Bio, Inc. Put Options Transaction History
Davidson Kempner Capital Management LP
- $1.82 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GRPH
# of Institutions
3Shares Held
637KCall Options Held
0Put Options Held
0About Graphite Bio, Inc.
- Ticker GRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,211,200
- Description
- Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...